Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
875.26
479.95
247.65
219.29
331.53
1.59
1.37
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
875.26
479.95
247.65
219.29
331.53
1.59
1.37
Raw Material Cost
430.98
283.69
212.87
205.84
152.25
1.13
1.01
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
22.23
19.93
16.32
12.49
6.20
0.34
0.09
Selling and Distribution Expenses
168.66
58.48
36.07
18.03
5.46
3.42
4.23
Other Expenses
-2.22
-1.99
-1.63
-1.25
-0.62
0.02
0.07
Total Expenditure (Excl Depreciation)
599.63
342.17
248.94
223.87
157.71
5.11
6.01
Operating Profit (PBDIT) excl Other Income
275.59999999999997
137.79999999999998
-1.3
-4.6000000000000005
173.79999999999998
-3.5
-4.6000000000000005
Other Income
-8.62
0.67
-0.40
-0.56
5.42
1.78
0.00
Operating Profit (PBDIT)
287.54
157.42
15.90
8.06
187.00
-1.50
-4.46
Interest
22.23
19.93
16.32
12.49
6.20
0.34
0.09
Exceptional Items
0.00
-8.69
-30.48
-402.02
-3.55
-3.61
-2.39
Gross Profit (PBDT)
444.28
196.26
34.77
13.45
179.28
0.45
0.36
Depreciation
20.53
18.97
17.59
13.20
7.76
0.24
0.18
Profit Before Tax
244.78
109.83
-48.49
-419.65
169.49
-5.69
-7.12
Tax
64.42
15.02
-5.07
13.09
0.97
0.00
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
70.79
52.10
-45.79
-424.78
132.59
-5.69
-7.12
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
-0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
70.79
52.10
-45.79
-424.78
132.59
-5.69
-7.12
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
109.57
42.71
2.36
-7.96
35.93
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
180.36
94.81
-43.42
-432.74
168.53
-5.69
-7.12
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
329.45
132.44
61.45
95.86
114.65
-1.13
1.86
Earnings per share (EPS)
10.48
9.69
-10.39
-100.36
33.55
-175.8
-294.06
Diluted Earnings per share
10.48
9.69
-10.39
-100.36
33.55
-175.8
-294.06
Operating Profit Margin (Excl OI)
31.49%
28.71%
-0.52%
-2.09%
52.43%
-222.03%
-339.63%
Gross Profit Margin
30.31%
26.84%
-12.48%
-185.35%
53.46%
-343.85%
-507.68%
PAT Margin
8.09%
10.85%
-18.49%
-193.7%
39.99%
-358.77%
-520.82%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is 82.39% vs 93.82% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is 90.30% vs 318.43% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is 88.90% vs 861.96% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is 11.56% vs 22.09% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has improved from Dec 2024
Compare Annual Results Of Nutex Health, Inc. With
Figures in Million
Consolidate Annual Results
Change(USD)
Change(%)
Net Sales
875.26
18.53
856.73
4,623.48%
Other Operating Income
0.00
0.00
0.00
Total Operating income
875.26
18.53
856.73
4,623.48%
Raw Material Cost
430.98
12.49
418.49
3,350.60%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
22.23
0.07
22.16
31,657.14%
Selling and Distribution Expenses
168.66
8.96
159.70
1,782.37%
Other Expenses
-2.22
0.12
-2.34
-1,950.00%
Total Expenditure (Excl Depreciation)
599.63
22.75
576.88
2,535.74%
Operating Profit (PBDIT) excl Other Income
275.62
-4.22
279.84
6,631.28%
Other Income
-8.62
0.00
-8.62
Operating Profit (PBDIT)
287.54
-2.70
290.24
10,749.63%
Interest
22.23
0.07
22.16
31,657.14%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
444.28
6.05
438.23
7,243.47%
Depreciation
20.53
1.51
19.02
1,259.60%
Profit Before Tax
244.78
-4.29
249.07
5,805.83%
Tax
64.42
0.00
64.42
Provisions and contingencies
0
0
0.00
Profit After Tax
70.79
-4.29
75.08
1,750.12%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
70.79
-4.29
75.08
1,750.12%
Share in Profit of Associates
0
0
0.00
Minority Interest
109.57
0.00
109.57
Other related items
0.00
0.00
0.00
Consolidated Net Profit
180.36
-4.29
184.65
4,304.20%
Equity Capital
0
0
0.00
Face Value
0.00
0.01
0.00
Reserves
329.45
12.09
317.36
2,624.98%
Earnings per share (EPS)
10.48
-2.93
13.41
457.68%
Diluted Earnings per share
10.48
-2.93
13.41
457.68%
Operating Profit Margin (Excl OI)
31.49%
-22.75%
0.00
54.24%
Gross Profit Margin
30.31%
-14.98%
0.00
45.29%
PAT Margin
8.09%
-23.15%
0.00
31.24%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 87.53 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 82.39% vs 93.82% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 18.04 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 90.30% vs 318.43% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 29.62 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 88.90% vs 861.96% in Dec 2024
Annual - Interest
Interest 2.22 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 11.56% vs 22.09% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 31.49%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has improved from Dec 2024






